Product Dossier
RIVAROXABAN-TEVA
Product Dossier for RIVAROXABAN-TEVA (rivaroxaban, Teva Pharma). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Teva Pharma
- Active ingredient: rivaroxaban
- Therapeutic area: Cardiology
- Related brand: XARELTO
- Related brand: RELABAN
- Related brand: RIVAXIB
- Same area: ATOZET
- Same area: OPSUMIT
What it is
RIVAROXABAN-TEVA is available in film-coated tablets containing 2.5 mg, 10 mg, 15 mg, or 20 mg of rivaroxaban.
Regulatory history
RIVAROXABAN-TEVA was first listed on the ARTG on 17 May 2022. Eight variants are registered, comprising the 2.5 mg, 10 mg, 15 mg, and 20 mg strengths in both blister pack and bottle presentations.